Empagliflozin add-on to Insulin in Type 1 Diabetes Mellitus Over 28 Days

NCT01969747 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
75
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Boehringer Ingelheim

Collaborators